Clopidogrel treatment before percutaneous coronary intervention reduces adverse cardiac events

Journal of Invasive Cardiology

Volumn 14, Issue 5, 2002, Pages 243-246

  Berglund, Ulf ^a   Richter, Arina ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Platelet inhibition

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; TIROFIBAN;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG SAFETY; FEMALE; HEART DISEASE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; REVASCULARIZATION; THROMBOCYTE AGGREGATION INHIBITION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0036256999     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty
2. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
3. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade
4. Clopidogrel. A review of its use in the prevention of atherothrombosis
5. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: Enhanced inhibitory effects of combination therapy
6. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation
7. A randomized comparison of antiplatelet with anticoagulant therapy after the placement of coronary artery stents
8. Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management
9. Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events. Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial
10. Does preprocedural ticlopidine treatment modify the short-term outcome after coronary angioplasty?
11. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
12. Myonecrosis after revascularization procedures
13. Acute and subacute stent occlusion. Risk-reduction by ionic contrast media
14. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization